Menu
Back to User profile » Dr Xiwen Liao
Papers published by Dr Xiwen Liao:
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
Wu Y, Ou S, Liao X, Han C, Yang C, Qin W, Tan Y, Lao Q, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:111-120
Published Date: 7 February 2023
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
Huang H, Liao X, Zhu G, Han C, Wang X, Yang C, Zhou X, Liang T, Huang K, Peng T
Pharmacogenomics and Personalized Medicine 2022, 15:277-300
Published Date: 29 March 2022
Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma
Zhu YZ, Liao XW, Yin W, Wei HM
International Journal of General Medicine 2022, 15:1131-1146
Published Date: 4 February 2022
High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma
Wei YG, Yang CK, Wei ZL, Liao XW, He YF, Zhou X, Huang HS, Lan CL, Han CY, Peng T
International Journal of General Medicine 2022, 15:609-621
Published Date: 14 January 2022
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis
Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T
Journal of Hepatocellular Carcinoma 2021, 8:1323-1338
Published Date: 3 November 2021
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma
Ruan GT, Gong YZ, Zhu LC, Gao F, Liao XW, Wang XK, Zhu GZ, Liao C, Wang S, Yan L, Xie HL, Zhou X, Liu JQ, Shao MN, Gan JL
OncoTargets and Therapy 2020, 13:9389-9405
Published Date: 23 September 2020
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma
Wang SJ, Wang Q, Zhang X, Liao X, Wang G, Yu L, Zhang W, Zhou Q, Hu S, Yuan W
Cancer Management and Research 2018, 10:5807-5824
Published Date: 16 November 2018
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T
Cancer Management and Research 2018, 10:3255-3271
Published Date: 5 September 2018
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T
Cancer Management and Research 2018, 10:2537-2551
Published Date: 10 August 2018
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T
Cancer Management and Research 2018, 10:1713-1726
Published Date: 25 June 2018
Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma
Liu X, Han C, Liao X, Yu L, Zhu G, Su H, Qin W, Lu S, Ye X, Peng T
Cancer Management and Research 2018, 10:1027-1036
Published Date: 4 May 2018
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma
Liao X, Yu L, Liu X, Han C, Yu T, Qin W, Yang C, Zhu G, Su H, Peng T
Cancer Management and Research 2018, 10:953-967
Published Date: 1 May 2018
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T
Cancer Management and Research 2018, 10:787-803
Published Date: 13 April 2018
Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T
Cancer Management and Research 2018, 10:679-696
Published Date: 10 April 2018
Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
Huang R, Liao X, Li Q
OncoTargets and Therapy 2018, 11:163-173
Published Date: 28 December 2017
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
Huang R, Liao XW, Li Q
OncoTargets and Therapy 2017, 10:5243-5254
Published Date: 2 November 2017
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T
OncoTargets and Therapy 2017, 10:4493-4506
Published Date: 12 September 2017
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma
Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T
OncoTargets and Therapy 2017, 10:3719-3732
Published Date: 24 July 2017